Stem-cell Therapy For Parkinson's Shows 'strong Promise' In Relieving Symptoms

With astir 1 cardinal group surviving pinch Parkinson’s disease successful nan U.S. — and 90,000 getting caller diagnoses each twelvemonth — nan title is connected for a cure.

Researchers astatine Memorial Sloan Kettering Cancer Center (MSK) person announced advancement connected that beforehand — they person developed a caller therapy that uses stem cells to dainty precocious Parkinson’s.

In nan shape 1 trial, nan researchers utilized donated stem cells (taken from early-stage embryos) to create nervus cells (neurons) and transplanted them into nan brains of 12 Parkinson’s patients, according to a property merchandise from MSK.

NEW DRUG FOR PARKINSON’S SHOWN TO BE EFFECTIVE IN CLINICAL TRIALS: 'VERY ENCOURAGED'

Once nan cells are injected, they nutrient dopamine, a hormone successful nan encephalon that helps pinch activity and coordination.

(One of nan hallmarks of Parkinson’s is debased levels of dopamine, which causes nan emblematic symptoms of tremors, stiffness, equilibrium issues and trouble walking.)

Around 1 cardinal group are surviving pinch Parkinson’s illness successful nan U.S., pinch 90,000 getting caller diagnoses each year. (iStock)

After 18 months, nan injected cells had "taken clasp successful nan encephalon pinch nary superior broadside effects," nan researchers reported. 

Based connected nan MDS-UPDRS — a ratings standard for symptoms developed by nan International Parkinson and Movement Disorder Society — nan participants knowledgeable "noticeable improvements," particularly nan group that received a higher dose.

Patients successful nan high-dose group reported 2.7 hours of further "on time" each day.

"Neurologists opportunity things usually get a small spot worse each twelvemonth pinch this disease, meaning nan people goes up by a fewer points," study co-author Lorenz Studer, MD, head of MSK’s Center for Stem Cell Biology, said successful nan property release. 

"In our study, not only did nan people not get worse, it dropped by much than 20 points successful nan high-dose group."

The researchers utilized donated stem cells (taken from early-stage embryos) to create nervus cells (neurons) and transplanted them into nan brains of 12 Parkinson’s patients. (iStock)

On average, patients successful nan high-dose group reported 2.7 hours of further "on time" — indicating periods of normal functioning pinch minimal symptoms — "a consequence that could beryllium rather meaningful for their mundane life," Studer noted.

Given nan occurrence of nan shape 1 trial, nan U.S. Food and Drug Administration (FDA) has granted support for nan researchers to spell consecutive to a phase 3 objective trial successful a overmuch larger diligent group — astir 100 group — which will return spot successful nan first half of 2025.

The findings were published successful nan diary Nature.

PARKINSON’S CASES COULD DOUBLE GLOBALLY BY 2050, STUDY REVEALS

"The study showed that processing circumstantial nervus cells from quality embryonic stem cells successful nan lab, past injecting them successful nan encephalon of group pinch Parkinson’s disease, is safe and holds important committedness arsenic a possible early treatment," lead study writer Viviane Tabar, MD, chair of nan Department of Neurosurgery astatine Memorial Sloan Kettering Cancer Center successful New York City, told Fox News Digital.

"The findings were rewarding, arsenic this activity is much than a twelve years successful nan making." 

‘Major measurement forward’

Dr. Mary Ann Picone, aesculapian head of nan MS Center astatine Holy Name Medical Center successful Teaneck, New Jersey, said that cells for nan curen of Parkinson's illness could connection imaginable for not only slowing disability, but besides stopping progression and bringing astir betterment successful centrifugal function.  

"Although location is consequence progressive successful nan immune suppression basal earlier nan stem compartment implantation and nan process itself, it would beryllium a awesome measurement guardant successful replacing nan dopaminergic neurons mislaid successful nan disease," Picone, who was not progressive successful nan study, told Fox News Digital. 

CLICK HERE TO GET THE FOX NEWS APP

Levodopa, presently nan first-line curen for Parkinson’s, is constricted successful that patients request greater dosage amounts arsenic clip goes on, according to Picone — "and regulating disconnected and connected periods of either stiffness aliases dyskinesias (uncontrolled musculus movements) becomes much difficult." 

After 18 months, nan injected cells had "taken clasp successful nan encephalon pinch nary superior broadside effects," nan researchers reported.  (iStock)

Dr. Ann Murray, head of activity disorders astatine WVU Rockefeller Neuroscience Institute successful West Virginia, referred to nan study arsenic "unbelievably exciting" for Parkinson’s patients. 

"Although nan extremity of this peculiar investigation task was to guarantee safety, getting that important objective betterment successful nan UPDRS is perfectly groundbreaking," Murray told Fox News Digital. (She besides was not progressive successful nan study.) 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"This is conscionable nan first measurement successful getting this type of therapy approved for patients suffering from Parkinson's disease, but this is an astonishing first measurement for nan imaginable benefits of stem compartment encephalon therapy."

Potential limitations

There were immoderate limitations associated pinch nan study, Tabar noted.

"This is simply a mini study designed to show information — it is captious to behaviour a larger, well-controlled study to beryllium that nan curen so works, different referred to arsenic a Phase 3 ‘efficacy’ study," she said.

"This is an astonishing first measurement for nan imaginable benefits of stem compartment encephalon therapy."

These early findings, however, are "suggestive of a beardown promise."

"I deliberation we tin yet opportunity that stem cells, erstwhile derived and differentiated properly, clasp awesome committedness to repair nan encephalon successful Parkinson’s and perchance successful other conditions someday," Tabar said.

For much Health articles, visit www.foxnews.com/health

The compartment therapy was developed astatine MSK and was licensed to BlueRock Therapeutics successful Massachusetts, which funded nan study.